Cellectis
CLLS
24 hedge funds and large institutions have $17.9M invested in Cellectis in 2025 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 8 reducing their positions, and 6 closing their positions.
6% more capital invested
Capital invested by funds: $16.9M → $17.9M (+$990K)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
2.56% less ownership
Funds ownership: 18.87% → 16.31% (-2.6%)
11% less funds holding
Funds holding: 27 → 24 (-3)
38% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 8
50% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$49.8K |
| 2 |
Morgan Stanley
New York
|
+$8.67K |
| 3 |
BNP Paribas Financial Markets
Paris,
France
|
+$4.62K |
| 4 |
Raymond James Financial
St Petersburg,
Florida
|
+$1.64K |
| 5 |
LPL Financial
San Diego,
California
|
+$1.32K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS AM
Chicago,
Illinois
|
-$2.23M |
| 2 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$172K |
| 3 |
Millennium Management
New York
|
-$98.5K |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$50K |
| 5 |
OMC
Old Mission Capital
Chicago,
Illinois
|
-$31.4K |
CLLS Hedge Fund Activity: Q2 2025 in Review
24 of the 7,604 institutional investors tracked by Wall St. Rank reported a position in Cellectis (CLLS) for Q2 2025, worth a combined $17.9M — up 5.9% from $16.9M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of CLLS and 3 opened new positions — a net loss of 3 holders — while 8 trimmed existing stakes and 5 added.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $49.8K. The largest seller was UBS AM, cutting an estimated $2.23M.
- 24 institutional investors held Cellectis (CLLS) as of Q2 2025, down from 27 in Q1 2025.
- Funds reported $17.9M of Cellectis stock for Q2 2025, up 5.9% quarter-over-quarter.
- 3 funds opened new Cellectis positions in Q2 2025 and 6 closed out, a net change of -3 holders.
- The largest Cellectis buyer in Q2 2025 was Susquehanna International Group, an estimated $49.8K added.
- The largest Cellectis seller in Q2 2025 was UBS AM, an estimated $2.23M sold.
Based on aggregated 13F filings for Q2 2025.